Transforaminal Epidural Injections (CPB 0722, reviewed 2026-10-14)
Summary
Aetna's Clinical Policy Bulletin 0722 covers transforaminal epidural steroid injections (TFESIs) performed with imaging guidance (fluoroscopy or CT) when the criteria for diagnostic or therapeutic use are met. Diagnostic selective TFESIs are considered medically necessary for identifying the etiology of pain in persons with symptoms suggestive of chronic radiculopathy when the diagnosis remains uncertain after standard evaluation. An initial therapeutic TFESI is considered medically necessary for radiculopathy when non-invasive measures such as physical therapy and non-narcotic analgesics have failed or become intolerant, and additional therapeutic TFESIs are considered medically necessary when the initial injection produced at least two specified outcomes for at least 2 weeks. Aetna considers TFESIs at more than two contiguous vertebral levels or more than four TFESIs in a single session not medically necessary.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.